"The regulatory authorities are really set up around the belief that people who are distributing pharmaceutical products are people who are playing by the rules, " Inkster says.
Further, by producing and then distributing these summaries to his customers, Iola was deemed to have violated NASD Conduct Rules 2110 (for conduct before December 15, 2008), 2210(d)(1)(A) and 2210(d)(1)(B), and FINRA Rule 2010 (for conduct after December 14, 2008).